CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2022	Sep. 30, 2021
Current Assets:
Cash And Cash Equivalents	$ 34,282,872	$ 36,060,148
U.s. Treasury Bills	0	6,151,385
Receivables	0	54,922
Prepaid Expenses	986,872	998,482
Supplies Used For R&d And Manufacturing	2,005,296	2,006,584
Total Current Assets	37,275,040	45,271,521
Finance Lease Right Of Use Assets	11,808,291	12,691,921
Operating Lease Right Of Use Assets	1,971,746	2,056,178
Property And Equipment, Net	12,870,911	13,663,562
Patent Costs, Net	234,658	275,866
Deposits	0	1,910,917
Total Assets	64,160,646	75,869,965
Current Liabilities:
Accounts Payable	1,316,542	1,675,813
Accrued Expenses	1,058,365	859,216
Due To Employees	488,105	265,993
Derivative Instruments	0	437,380
Lease Liabilities, Current Portion	1,611,273	698,665
Total Current Liabilities	4,474,285	3,937,067
Finance Lease Obligations, Net Of Current Portion	12,494,026	13,252,364
Operating Lease Obligations, Net Of Current Portion	1,939,787	2,021,308
Other Liabilities	125,000	125,000
Total Liabilities	19,033,098	19,335,739
Stockholders' Equity
Preferred Stock, $.01 Par Value-200,000 Shares Authorized; -0- Shares Issued And Outstanding	0	0
Common Stock, $.01 Par Value - 600,000,000 Shares Authorized; 43,304,602 And 43,207,183 Shares Issued And Outstanding At March 31, 2022 And September 30, 2021, Respectively	433,046	432,072
Additional Paid-in Capital	481,497,012	474,298,566
Accumulated Deficit	(436,802,510)	(418,196,412)
Total Stockholders' Equity	45,127,548	56,534,226
Total Liabilities And Stockholders' Equity	$ 64,160,646	$ 75,869,965